Dr. Michael Har-Noy Creates The Unique Mirror EffectTM Technology

1
Dr. Michael Har-Noy Creates The Unique Mirror
EffectTM Technology
2
Dr. Michael Har-Noy Discusses AlloStimTM In The
Treatment Of HIV
In January of last year, Dr. Michael Har-Noy
administered AlloStimTM to a single test patient
with HIV. Dr. Michael Har-Noy theorized that
AlloStimTM might cause the patients immune
system to flush out the reservoir of HIV and
create a potential cure. After multiple doses of
AlloStimTM, the patients viral load is down and
CD4 count is at a record high.
3
Dr. Michael Har-Noy Compares AlloStimTM to
Checkpoint Blockade Therapy
Dr. Michael Har-Noy of Immunovative Therapies,
Ltd. says that checkpoint blockade drugs block
molecules used by cancer cells to hide from the
immune system.
Yervoy and Opdivo are examples of such drugs.
Dr. Michael Har-Noy notes, however, that
checkpoint blockade drugs work only if there is
an existing intact immune response and are
therefore effective in a minority of tumors.
Immunovative Therapies, Ltd.s AlloStimTM, says
Dr. Michael Har-Noy, creates its own immune
response and may therefore be potentially
effective in all kinds of tumors.
4
Dr. Michael Har-Noy Discusses Upcoming Pivotal
Trial In Colorectal Cancer
Dr. Michael Har-Noy is planning to conduct a
pivotal Phase II/III randomized trial of
AlloStimTM in the treatment of KRAS gene positive
metastatic colon cancer. Dr. Michael Har-Noy
says there is no approved third line treatment
option for patients with this disease. Successful
completion of this trial would lead to marketing
approval of AlloStimTM. Dr. Michael Har-Noy
plans to conduct the trial in Thailand as well as
the United States.
5
http//michaelharnoy.wordpress.com/